✦ LIBER ✦

Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy

✍ Scribed by Maurie Markman

Book ID: 102108510
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 44 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23893

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of reliability of CA125 response cr

Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy

✍ Nilofer S. Azad; Christina M. Annunziata; Seth M. Steinberg; Lori Minasian; Ahal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract ## BACKGROUND CA125 is an accepted indicator of epithelial ovarian cancer (EOC) response and is used to monitor patients treated with cytotoxic chemotherapy. It is uncertain how CA125 is affected by molecularly targeted drugs. In this pilot study, the authors analyzed the utility of CA

Reply to Lack of reliability of CA125 re

Reply to Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy

✍ Nilofer Azad; Lori Minasian; Elise Kohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Human anti-chimeric antibody levels corr

Human anti-chimeric antibody levels correlate with lack of response and infusion reactions following infliximab therapy

✍ Richard J. Farreli; Mazen Alsahli; Kenneth R. Falchuk; Mark A. Peppercorn; Pierr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 199 KB

1140 Categories of response to first lin

1140 Categories of response to first line VEGF receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma

✍ Busch, J.F.; Seidel, C.; Goranova, I.; Erber, B.; Peters, R.; Friedersdorff, F.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 108 KB